Matches in Nanopublications for { ?s ?p "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624903.RASFKlMSzUGcaWIsXg1vPzonvpYAS5cVgs4bOP_uwzvFo130_provenance.
- assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621048.RAtzxX8dxmzBSA2FH0mMO5fTsR92jbNCQdPWXlC-ygnsc130_provenance.
- NP817560.RAklUD7PtHS93R3XU6JuOKGl7z9ViJrYhPEZAjZvQvOBg130_assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817560.RAklUD7PtHS93R3XU6JuOKGl7z9ViJrYhPEZAjZvQvOBg130_provenance.
- NP817561.RAq1h5CnwG5aCEaQ5fmmGMjyJ6yICZKG8CWbism1Tbj9E130_assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817561.RAq1h5CnwG5aCEaQ5fmmGMjyJ6yICZKG8CWbism1Tbj9E130_provenance.
- NP817563.RArhUyhHuhd_hKmnvLg3CtRk0I0V8dANmlgZ5RosQFLfM130_assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817563.RArhUyhHuhd_hKmnvLg3CtRk0I0V8dANmlgZ5RosQFLfM130_provenance.
- NP623764.RAI-qtxEOaJSVrjAHHxcbM3Kn-DR2VpxPdgd6hQ9OC7pM130_assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623764.RAI-qtxEOaJSVrjAHHxcbM3Kn-DR2VpxPdgd6hQ9OC7pM130_provenance.
- NP622453.RA4r9aPYkDnkVj1Ux7rZN1xY1uHlUEfPg6rdTzPEeByCg130_assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622453.RA4r9aPYkDnkVj1Ux7rZN1xY1uHlUEfPg6rdTzPEeByCg130_provenance.
- NP817562.RAJV435owO7iIt9yiZDfKq_qDkFyDHoWO3WAkxORnn0ms130_assertion description "[We identified the mechanism involved in ATO action on B-CLL cells and show that the combination of low doses of ATO and PI3K inhibitors efficiently induces B-CLL cell death.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817562.RAJV435owO7iIt9yiZDfKq_qDkFyDHoWO3WAkxORnn0ms130_provenance.